Want to join the conversation?
Pharmaceutical company $MYL said that in Dec. 2015 it submitted its ANDA for fluticasone propionate 100, 250, 500 mcg and salmeterol 50 mcg inhalation powder to the US FDA. This product is the generic version of Advair Diskus indicated for treatment of asthma and reducing aggravation in patients with chronic obstructive pulmonary disease.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?